Skip to Content Skip to Search
DNA double helix

About us

We are a science-led global healthcare company with a purpose to help people do more, feel better and live longer.

At GSK, we are driven by a purpose to help people do more, feel better and live longer.

In India, our long legacy is testament to our commitment and the trust reposed in us over generations.

Working with us means the opportunity to make a life-saving difference in the health of millions of people while enabling you to grow and be the best you can be.

People are at the heart of everything we do. We aim to bring differentiated, high-quality and high performing healthcare products to those who need them with our global businesses, scientific and technical know-how and talented people.  

Innovation

Innovation is at the heart of delivering our purpose by using our science to develop pharmaceuticals and vaccines. We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and get ahead of disease.

  • 2

    global R&D centres based in India

  • Fluarix Tetra

    GSK's quadrivalent influenza vaccine launched in 2020

  • Nucala

    launched in 2019 for protection against exacerbations and oral steroid dependency in severe eosinophilic asthma

  • Menveo

    GSK’s quadrivalent Meningococcal Conjugate vaccine, launched in 2019

Performance

We deliver growth by investing effectively in our business, developing our people and executing competitively.

  • #1

    in vaccines self-pay segment

  • 4

    GSK brands among top 50 brands in the Indian pharmaceuticals market (IPM)

  • Over Rs. 3,100 crores

    revenue from operations in 2020-21

Trust

We are a responsible company - using our science and technology to address health needs, we are focused on making our products affordable and available and being a modern employer.

  • 94%

    employee engagement score on our latest employee survey

  • Over 3 billion

    tablets donated to to the WHO for ‘Partnering India to Eliminate Lymphatic Filariasis’ since 2001

  • #1

    in Access to Medicines Index

Bringing innovative products and improving access to them is critical to helping build stronger, healthier communities. We leverage our legacy of over 90 years in India to help transform people’s health through our extensive product portfolio that includes prescription medicines and vaccines. We are the leaders in anti-infectives and dermatology in the pharmaceuticals industry and in vaccines too we are the leaders in the private segment.

  • 1924

    GSK started its journey in India and was listed on the National Stock Exchange in 1969

  • #1

    We are the market leader in dermatology and in vaccines in the private segment

  • Over Rs. 3,000 crore

    turnover (as on 31 March, 2021)

  • Over 4,000 people

    work in our advanced manufacturing facility, offices and sales force across India to ensure seamless access of our medicines and vaccines to our patients

What we do

We research, manufacture and make available a broad range of medicines and vaccines that benefit people.

We believe in performance sustainability across all aspects of our business. Our success over the years has depended on several factors including our foray into diverse segments, creating products that people value, making them widely accessible and operating efficiently. Our growth is backed by a strong reputation for genuine care towards patients.

How we do it

Everyone at GSK focuses on 3 priorities - Innovation, Performance, Trust

Our values and expectations are at the heart of everything we do and form an important part of our culture.

Values and expectations of GSk